Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- Artificial Intelligence (4)
- Big Data (1)
- Biology (3)
- Chemical Sciences (2)
- Computer Science (4)
- Cybersecurity (4)
- Decarbonization (1)
- Energy Storage (4)
- Environment (3)
- Exascale Computing (1)
- Frontier (2)
- Grid (2)
- Machine Learning (2)
- Materials (4)
- Materials Science (3)
- Microscopy (1)
- National Security (6)
- Neutron Science (22)
- Partnerships (1)
- Physics (4)
- Quantum Science (2)
- Security (3)
- Space Exploration (1)
Media Contacts
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.